Current treatment strategies with lenalidomide in multiple myeloma and future perspectives.
about
Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in KoreaCancer-related coagulopathy (Trousseau's syndrome): review of the literature and experience of a single center of internal medicine.Design and biological characterization of hybrid compounds of curcumin and thalidomide for multiple myeloma.Treatment with lenalidomide induces immunoactivating and counter-regulatory immunosuppressive changes in myeloma patients.Circulating immune cell phenotype can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma.
P2860
Current treatment strategies with lenalidomide in multiple myeloma and future perspectives.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Current treatment strategies w ...... eloma and future perspectives.
@en
Current treatment strategies w ...... eloma and future perspectives.
@nl
type
label
Current treatment strategies w ...... eloma and future perspectives.
@en
Current treatment strategies w ...... eloma and future perspectives.
@nl
prefLabel
Current treatment strategies w ...... eloma and future perspectives.
@en
Current treatment strategies w ...... eloma and future perspectives.
@nl
P2860
P50
P356
P1433
P1476
Current treatment strategies w ...... yeloma and future perspectives
@en
P2093
Mario Boccadoro
Roberto Mina
P2860
P304
P356
10.2217/FON.12.124
P407
P577
2012-10-01T00:00:00Z